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ABSTRACT Two distinct types of cell death have been described: apoptosis and necrosis.
However, it is becoming increasingly clear that the differences between these two types are far less
numerous than initially thought. Morphological analyses might provide important information to
distinguish apoptotic from necrotic samples. We recently reported that in necrotic, but not apopto-
tic, HL-60 human myeloid leukaemia cells, the nuclear protein topoisomerase II concentrated in
nucleoli. In order to ascertain whether or not this phenomenon was restricted to a peculiar cell type
or could be detected also in cells of lymphoid lineage, we performed an investigation aimed at
defining the localization of topoisomerase II in apoptotic and necrotic Jurkat human T lympho-
blastoid cells. Immunofluorescence staining demonstrated that topoisomerase II was excluded
from the condensed chromatin of apoptotic cells, whereas in necrotic cells it was localized in discrete
nuclear dots. Immuno-electron microscopy analysis showed that topoisomerase II was undetect-
able in nucleoli of normal and apoptotic cells, whereas it was present in the nucleolus of necrotic
cells irrespectively of the type of inducer used (ethanol, H2O2, HgCl2). Taken together, our findings
identify topoisomerase II as a potential morphological marker useful to discriminate between
apoptotic and necrotic cells. Microsc. Res. Tech. 62:192–200, 2003. © 2003 Wiley-Liss, Inc.
INTRODUCTION
Cell death is said to occur by two alternative, oppo-
site modes: apoptosis, a programmed form of cell death,
and necrosis, an unordered and accidental form of cel-
lular dying (Buja et al., 1993; Majno and Joris, 1995).
The term apoptosis, defined as a controlled type of cell
death that can be induced by a plethora of physiologic
and pharmacological treatments, was first employed by
Kerr et al. (1972) mainly on the basis of morphological
criteria: cell shrinkage, condensation and margination
of chromatin, cytoplasmic vacuolization, and final cell
splitting in a number of “apoptotic bodies.” Subse-
quently, many biochemical changes have been recog-
nized to occur during apoptosis, chiefs of which are
DNA fragmentation and protein cleavage (Hengartner,
2000). Necrosis is characterized by nuclear pyknosis, cy-
toplasmic swelling, and a progressive loss of membrane
integrity (Wyllie et al., 1980). An extensive body of liter-
ature exists on the apparent differences between apopto-
sis and necrosis (reviewed in Kanduc et al., 2002). For
example, while apoptosis is an energy-dependent method
of cellular deletion without inflammation, necrosis is as-
sociated with inflammation; apoptosis is the consequence
of mild injuries whereas necrosis occurs in response to
more severe forms of the same types of injury.
More recently, however, several investigations have
highlighted the fact that the differences between ne-
crosis and apoptosis might be less numerous than ini-
tially believed. Indeed, some of the biochemical
changes that take place during apoptosis have been
demonstrated to occur also during necrosis: the inner
mitochondrial membrane may become permeable to
ions and small molecules during both necrosis and
apoptosis (Dynlacht et al., 1999). Furthermore, the ac-
tivation of cysteine proteases and the cleavage of poly-
(ADP-ribose) polymerase and other proteins have been
documented to occur during both modes of cell death
(Casiano et al., 1998; Shah et al., 1996). The differences
in the protein cleavage pattern of apoptotic and ne-
crotic cells might be important for a differential diag-
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nosis between these two conditions (Casiano et al.,
1998).
However, it has been suggested that morphological
criteria might also be an effective tool to distinguish
apoptotic from necrotic changes (Kanduc et al., 2002).
We recently demonstrated that in necrotic, but not in
apoptotic, HL-60 human leukemia cells, the distribu-
tion of the abundant nuclear protein DNA topoisomer-
ase II, underwent dramatic changes consisting of the
appearance of large and bright dots apparently local-
ized to nucleoli (Bortul et al. 2001). These findings
suggested that the distribution of DNA topoisomerase
II might be considered, in principle, a differential
morphological criterion of necrotic cell death. However,
it remained to be established that such a redistribution
was not restricted to HL-60 cells that underwent ne-
crotic death following exposure to ethanol.
In this study, we demonstrate that a similar redis-
tribution of DNA topoisomerase II localization takes
place in Jurkat human T leukemia cells treated with
different necrosis inducers. Indeed, by immuno-elec-
tron microscopy we detected topoisomerase II in nu-
cleoli of necrotic cells.
Our results seem to indicate that a change in the
spatial distribution pattern of topoisomerase II is a
consistent feature of necrotic cell death and could,
therefore, be used as a morphological criterion to dif-
ferentiate apoptotic from necrotic cells.
MATERIALS AND METHODS
Cell Culture and Induction of Apoptosis
or Necrosis
Jurkat human T cells were grown in RPMI
1640 medium containing 10% fetal calf serum at 37°C
in a humified atmosphere, and passaged every 3 days
by 5-fold dilution into fresh medium. For induction of
apoptosis with antibody to Fas (CD95/APO-1), cells
were washed twice in serum-free medium before the
addition of 200 ng/ml of monoclonal antibody CH-11
(Medical and Biological Laboratories, Watertown, MA).
For treatment with camptothecin (5 M) or etoposide
(150 M), the drugs were added to cells growing in the
complete medium. To induce necrosis, cells were
treated with 40 M HgCl2, or 10% ethanol, or 0.1%
H2O2 (Casiano et al., 1998). All treatments inducing
apoptosis or necrosis were performed for 7 hours, un-
less otherwise indicated.
Flow Cytometry
For identification and quantification of apoptosis,
cells were fixed with 70% ethanol at 4°C for 30 minutes.
Samples were stained with 50 g/ml propidium iodide
(PI) and 50 l of a 1 mg/ml RNase A solution. They
were then incubated at 37°C for 30 minutes and ana-
lyzed by a FACscan (Becton Dickinson, Palo Alto, CA)
equipped with an argon ion laser tuned at 488 nm to
excite PI. PI red fluorescence was collected on a linear
scale and apoptosis was identified as a subdiploid area.
To analyze necrosis, the Annexin V-7 amino-actinomy-
cin D (7-AAD) staining kit (Beckman-Coulter, Miami,
FL) was employed. Annexin V, conjugated with fluo-
rescein isothiocyanate (FITC), binds to cells expressing
phosphatidylserine on the outer layer of the plasma
membrane while 7-AAD stains DNA of cells with a
damaged plasma membrane. This allows discrimina-
tion of undamaged cells (unstained with either fluoro-
chrome) from apoptotic cells (stained only with An-
nexin V-FITC) or necrotic cells (stained with both An-
nexin V-FITC and 7-AAD).
DNA Gel Electrophoresis
DNA was extracted using standard procedures (Fal-
cieri et al., 2000). Five micrograms DNA/lane were
loaded on 1.8% agarose gel in Tris-borate/EDTA buffer,
stained with 0.5 g/ml ethidium bromide, and visual-
ized on a UV transilluminator.
Conventional Transmission Electron
Microscopy (TEM)
Cells were fixed for 1 hour at room temperature with
2.5% glutaraldehyde buffered in phosphate buffer,
postfixed in 1% OsO4 in the same buffer, dehydrated in
a graded ethanol series, and embedded in Araldite.
Thin sections were stained with uranyl acetate and
lead citrate and observed using a Philips CM
10 electron microscope (Falcieri et al., 2000). In some
cases, samples were processed as for immuno-electron
microscopy (Luchetti et al., 2002).
Polyacrylamide Gel Electrophoresis
and Immunoblotting of Cell Lysates
Cells were sedimented at 1,000g for 10 minutes and
washed twice in phosphate buffered saline (PBS) con-
taining the COMPLETE Protease Inhibitor Cocktail
(Roche Applied Science), according to the manufactur-
er’s instructions. Cells were then resuspended at
107/ml in lysis buffer containing 62.5 mM Tris-HCl,
pH 6.8, 2% sodium dodecylsulfate (SDS), 10% glycerol,
5% 2-mercaptoethanol, and the protease inhibitor cock-
tail. Lysates were boiled for 5 minutes to solubilize
protein, briefly sonicated to shear DNA, and stored at
80°C until required. Cell harvesting and lysate prep-
aration were conducted in the presence of the protease
inhibitor cocktail as a precaution to prevent further
proteolysis. Total protein from 1  106 cells was
separated by SDS-polyacrylamide gel electrophoresis
(SDS-PAGE) and electrophoretically transferred to ni-
trocellulose sheets using a semi-dry blotting appara-
tus. Sheets were saturated in PBS containing 5% nor-
mal goat serum (NGS) and 4% bovine serum albumin
(BSA) for 60 minutes at 37°C (blocking buffer), then
incubated overnight at 4°C in blocking buffer contain-
ing the monoclonal antibody to topoisomerase
II(Roche Applied Science) diluted 1:500. After four
washes in PBS containing 0.1% Tween 20, the sheets
were incubated for 30 minutes at room temperature
with peroxidase-conjugated anti-mouse IgG (Sigma
Chemical Co., St Louis, MO), diluted 1:5,000 in PBS-
Tween 20, and washed as above. Bands were visualized
by the enhanced chemiluminescence (ECL) method us-
ing Lumi-LightPlus (Roche Applied Science).
Protein Assay
Assays were performed as described by Bradford
(1976).
Immunofluorescent Staining
Cells in media were plated onto 0.1% poly-L-lysine-
coated glass slides and adhesion was allowed to pro-
ceed for 30 minutes at room temperature. Samples
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were fixed in freshly-prepared 4% paraformaldehyde in
PBS for 30 minutes at room temperature and then
permeabilized with 0.2% Triton X-100 for 10 minutes.
After several washes with PBS, nonspecific binding of
antibodies was blocked by a 30-minute incubation at
37°C with PBS, 2% BSA, 5% NGS. Slides were then
incubated for 3 hours at 37°C with the antibody to
topoisomerase II (diluted 1:50) in PBS, 2% BSA, 5%
NGS. Slides were then washed three times in PBS and
reacted with FITC-conjugated anti-mouse IgG (from
Sigma), diluted 1:200 in PBS, 2% BSA, 5% NGS for
1 hour at 37°C. Samples were subsequently washed
three times in PBS, stained with 0.01 g/ml 4,6-dia-
midino-2-phenylindole (DAPI) in PBS and mounted in
20 mM Tris-HCl, pH 8.2, 90% glycerol containing 2.3%
of the antifading agent 1,4-diazobicyclo-(2.2.2)-octane.
Slides were observed and photographed using a Zeiss
Axiophot epifluorescence microscope.
Immunogold Labeling and Electron Microscopy
Cells were fixed with 1% glutaraldehyde in 0.1 M
phosphate buffer, pH 7.4, for 1 hour and washed twice
in phosphate buffer. Samples were partially dehy-
drated up to 70% ethanol and embedded in London
Resin White (LRW). Thin sections were collected on
400-mesh nickel grids and incubated for 30 minutes at
room temperature in TBS blocking buffer (50 mM Tris-
HCl, pH 7.6, 1% sodium azide, 150 mM NaCl, 0.1%
BSA). The grids were treated with 5% NGS for
30 minutes at room temperature, and incubated over-
night at 4°C in the presence of the antibody to topo-
isomerase II, used at 1:100 dilution in blocking buffer.
After several washes in TBS buffer, the samples were
incubated in TBS buffer (pH 8.2) for 1 hour at room
temperature with 10-nm gold-conjugated goat anti-
mouse IgG (British Biocell International, Cardiff, UK)
diluted 1:100 in blocking buffer. After three washes in
TBS (pH 8.2) and one in distilled water, the grids were
counterstained with uranyl acetate and lead citrate.
Controls were represented by samples treated with the
secondary antibody alone: no gold particles were de-
tected (data not shown). All samples were examined
with a Philips CM 10 electron microscope operating at
80 kV (Luchetti et al., 2002).
RESULTS
Flow Cytometric Analysis
We first evaluated by means of flow cytometry the
efficacy of our inducers in causing apoptotic or necrotic
cell death. Apoptotic cells were identified as a subdip-
loid peak on the basis of PI staining, while necrotic
cells were distinguished using a combined Annexin
V-FITC/7-AAD staining. As shown in Figure 1, analy-
sis by flow cytometry showed that treatment with anti-
FAS, camptothecin, or etoposide resulted in a similar
percentage of apoptotic Jurkat cells, which ranged be-
tween 72 and 80%. The percentage of necrotic cells in
response to these treatments was very low (around
3–4%). Ethanol, H2O2 or HgCl2 were equally effective
in inducing Jurkat T cell death by necrosis, in a per-
centage which ranged between 83 and 91%. These
treatments caused apoptosis only in 4–5% of cells. Fig-
ure 2A shows that apoptotic cells were indeed stained
by Annexin V but not by 7-AAD, as expected, and a
subdiploid area was obtained by cell cycle analysis of
PI-stained samples. In contrast, necrotic cells were
7-AAD positive and Annexin V positive, and no subdip-
loid area was seen upon cell cycle analysis (Fig. 2B).
DNA Gel Electrophoresis
As a further control, we performed DNA gel electro-
phoresis. As shown in Figure 3, in camptothecin-
treated samples we detected the characteristic inter-
nucleosomal DNA fragmentation. Similar results were
seen in samples exposed to anti-FAS or etoposide (not
shown). In contrast, no DNA fragmentation was visible
in samples treated with ethanol. Similar results were
observed following exposure to either H2O2 or HgCl2
(not shown).
Conventional TEM
Jurkat cells, when examined at TEM, showed a large
nucleus, with a prominent nucleolus, and a thin cyto-
plasmic layer with a scarce organellar component (Fig.
4A). When triggered to apoptosis with camptothecin,
the well-known nuclear changes appeared such as elec-
tron-dense micronuclei (Fig. 4B). It is interesting that
some micronuclei, as the one presented in Figure 4B,
did not display a surrounding membrane. Usually, the
majority of micronuclei appear membrane-surrounded
even if, rarely, they are not (Columbaro et al., 1998). In
this case, the fate of the nuclear envelope has been
suggested to be “annulatae lamellae,” i.e., unusual
Fig. 1. Flow cytometric analysis of Jurkat T cells treated for
7 hours with agents producing apoptosis or necrosis. Results are the
mean  SD from three separate experiments and show the percentage
of apoptotic or necrotic cells in response to the different inducers. A:
Treatment with apoptosis inducers. B: Treatment with necrosis in-
ducers.
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Fig. 2. Representative histograms of apoptotic cells (A) or necrotic
cells (B) analyzed by flow cytometry. Top panels: Annexin V vs.
7-ADD (apoptotic cells are Annexin V /7-AAD-; necrotic cells are
Annexix V-/7-AAD ). Bottom panels: Cell cycle staining by PI:
apoptotic cells are identified in the pre G0/G1 area (subdiploid area
indicated by the arrows). Note that samples treated with necrosis
inducers do not display cells in the pre G0/G1 area (subdiploid area).
Cells have been treated with the inducers for 7 hours.
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structures formed by flattened cisternae consisting of
stacks of nuclear pore-containing membranes that
have been described occasionally in apoptosis (Falcieri
et al., 1994). Necrotic death, induced by a 7-hour treat-
ment with 10% ethanol, even if in the presence of a
general cell swelling and disruption, allowed a satis-
factory preservation of overall nuclear structure. This
was evident after 2.5% glutaraldehyde conventional
fixation, alcohol dehydration, and epoxy resin embedding
(Fig. 4C). Surprisingly, nuclear components were recog-
nizable also after a mild fixation, a partial dehydration,
and London Resin White embedding, i.e., the procedure
required for immuno-electron microscopy (Fig. 4D).
Western Blot Analysis
We next analyzed by Western blot the possible cleav-
age of topoisomerase II in apoptotic or necrotic sam-
ples. As shown in Figure 5, topoisomerase II was
cleaved after treatment with anti-FAS, camptothecin,
or etoposide. In contrast, no cleavage at all was de-
tected following exposure to ethanol, H2O2 or HgCl2.
Immunofluorescence Staining
The antibody to topoisomerase II gave a diffuse
fluorescent pattern when employed to immunostain
nuclei of control Jurkat cells (Fig. 6A). In apoptotic
Fig. 3. DNA gel electrophoresis
from control, camptothecin, and
ethanol treated Jurkat T cells. Mo-
lecular weight markers are at left.
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samples, the immunoreactivity was excluded from the
area of condensed chromatin revealed by DAPI stain-
ing (Fig. 6C–H). In necrotic samples, besides a diffuse
nucleoplasmic positivity, we detected 3–5 large fluores-
cent dots per nucleus (Fig. 6I–N). This suggested that
topoisomerase II could be concentrated in nucleoli.
Immuno-Electron Microscopy Analysis
In order to identify the nuclear domains of necrotic
Jurkat cells in which topoisomerase II concentrated,
we performed immuno-electron microscopy analysis.
The nucleoli of control cells were unlabeled (Fig. 7A).
Anti-topoisomerase II immunolabelling was then per-
formed in cells undergoing necrosis by means of etha-
nol (Fig. 7B), HgCl2 (Fig. 7C) or H2O2 (Fig. 7D). In all
of the three conditions, gold particles appeared mainly
localized within the nucleoli, mostly on their granular
component. In contrast, in nucleoli of apoptotic cells
treated with anti-FAS antibody for 2 hours (i.e., a time
frame in which nucleoli were still identifiable), nucleoli
were negative for topoisomerase II (Fig. 7E). Similar
results were observed when either camptothecin or
etoposide were employed to induce apoptosis (not
shown).
DISCUSSION
In this study, we have reported the results of an
investigation designed to analyze whether the changes
in the localization of topoisomerase II previously de-
scribed in HL-60 necrotic cells could also be detected in
Jurkat T human leukemia cells treated with three dif-
ferent necrosis inducers.
We first performed control experiments employing
flow cytometry analysis, DNA gel electrophoresis, and
TEM in order to verify that we dealt with populations
that were highly enriched in either apoptotic or ne-
crotic cells. We incubated cells for 7 hours with the
inducers because we found that shorter treatments did
not allow a reproducible identification of the apoptotic
ultrastructural features. On the other hand, longer
Fig. 4. Conventional TEM anal-
yses of Jurkat T cell. A: Araldite-
embedded control cell; B,C: campto-
thecin-and ethanol treated Araldite-
embedded cells, respectively; D:
LRW-embedded control cell. n: nu-
cleus; nu: nucleolus; m: micronu-
cleus. Scale bar: 1 m.
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incubation times induced in necrotic samples a general
cell disruption, which made it impossible to recognize
cell components.
Since we recently reported that topoisomerase II
was not proteolytically cleaved in HL-60 human leuke-
mia cells undergoing necrosis by ethanol treatment
(Bortul et al., 2001), we wanted to analyze whether or
not this was also true of Jurkat T cells. Western blot
analysis confirmed that topoisomerase II was not
cleaved after exposure to necrosis inducers, whereas it
was degraded to multiple fragments in apoptotic cells.
However, we could not rule out that the antibody we
used could not recognize different fragments present in
necrotic samples only, even though it should be empha-
sized that the amount of the native topoisomerase II
did not decrease in necrotic samples so that a cleavage
seems unlikely. In any case, Casiano et al. (1998) re-
ported also that in necrotic Jurkat T cells, topoisomer-
ase II was essentially uncleaved.
Immunofluorescence staining for topoisomerase II
showed that in apoptotic cells, it was always excluded
from the areas of compact chromatin. This is in agree-
ment with a previous study carried out in HL-60 cells
(Sugimoto et al., 1998).
In contrast, in necrotic Jurkat cells we detected in
each nucleus several brilliant and large dots, besides a
more diffuse staining. Immuno-electron microscopy al-
lowed us to conclude that the nucleoli of necrotic cells
were labeled by the antibody to topoisomerase II. On
the other hand, neither control nor apoptotic cells
showed any immunolabeling in nucleoli. In this con-
text, it should be emphasized that the nucleolus is one
of the nuclear domains that are more resistant to the
Fig. 6. Immunofluorescence staining of control, apoptotic, and ne-
crotic Jurkat T cells. Scale bar: 5 m.
Fig. 5. Western blotting analysis for topoisomerase II during
apoptosis or necrosis in Jurkat T cells. Cells (1  107) were lysed in
1 ml of electrophoresis sample buffer, briefly sonicated, and boiled.
Protein was separated by SDS-PAGE and transferred to nitrocellulose
sheets that were then probed with a monoclonal antibody. Protein
(80 g) was blotted to each lane. Bands were visualized by the ECL
method. The gel is representative of three separate experiments.
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apoptotic process (Martelli et al., 1999a,b). By immuno-
electron microscopy, some gold particles were also de-
tected in the nucleoplasm of necrotic cells and this is in
agreement with the results of the immunofluorescence
staining. From these data and those of Western blot-
ting experiments, it is deduced that in both necrotic
and apoptotic cells there is a non-nucleolar localization
of topoisomerase II that is in the form of fragments for
the apoptotic cells and uncleaved for the necrotic. At
present, we do not know the physiological meaning for
this.
Human topoisomerase II, once thought to be an
immobile, structural component of the chromosomal
scaffold or the interphase nucleoskeleton, has recently
been shown to be a very dynamic interaction partner of
these structures. Indeed, an investigation carried out
by means of stable overexpression of a chimera consist-
ing of topoisomerase II tagged with green fluorescent
protein, showed a dynamic behavior of the enzyme
during mitosis, the interphase, or in response to drug
treatment (Christensen et al., 2002). What might be
the functional significance of the intranucleolar topo-
isomerase II in necrotic cells? It has been proposed
that topoisomerase II is involved in DNA repair (e.g.,
Giocanti et al., 1993; Thielmann and Popanda, 1998).
On the other hand, agents that produce necrosis, such
as ethanol and H202, cause DNA damage (Lee et al.,
2002; Russo et al., 2001). We could, therefore, hypoth-
esize that the intranucleolar presence of topoisomerase
II might be related to DNA repair processes poten-
tially taking place in necrotic cells, even though ener-
gy-consuming activities such as DNA repair have yet
not been demonstrated to take place during necrosis.
The localization of topoisomerase II in the nucleolus
of healthy cells is still contentious. For several years,
the nucleolus-specific isoform of topoisomerase II was
considered to be the 	 (Govoni et al., 1995; Zini et al.,
1992). Subsequently, however, this conclusion has been
questioned (Chaly and Brown, 1996). Other investiga-
tors have shown that topoisomerase II was also de-
tectable in nucleoli (Christensen et al., 2002; Zini et al.,
1994). However, our results did not show the presence
of topoisomerase II in nucleoli of healthy Jurkat T
cells.
We would like to emphasize that HL-60 and Jurkat
cell lines, although both of hematopoietic lineage, are
different, since the former is of myeloid origin whereas
the latter is of lymphoid derivation. Conceivably, the
changes in the distribution pattern of topoisomerase
II are to be considered a consistent feature of necrotic
cells. In light of these findings, we propose that the
differential immunostaining pattern for topoisomerase
II we have identified may be very useful in the future
for allowing a differential diagnosis between necrotic
and apoptotic samples, especially in the context of
pathological processes in vivo, which has never been an
easy task if ultrastructural analysis could not be em-
Fig. 7. Immuno-electron microscopy analysis of control Jurkat T
cells (A), of cells after necrotic death induction by ethanol (B), HgCl2
(C), H2O2 (D), and of apoptotic cells treated with anti-FAS antibody
for 2 hours. Gold particles (arrowheads) immunolabeling topoisomer-
ase II appear mostly localized in nucleolar granular component. n:
nucleus; nu: nucleolus. Scale bar: 0.2 m.
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ployed (Columbano, 1995; Farber, 1994; Majno and
Joris, 1995). It might also be a useful tool to discrimi-
nate between apoptosis and necrosis in particular con-
ditions such as the very late stages of both processes
where a general cell disruption often occurs. In con-
trast, early necrotic and apoptotic features are gener-
ally well distinguishable: therefore, nucleolar localiza-
tion of topoisomerase II, if already detectable, could
only be considered an additional discriminating fea-
ture.
Moreover, future investigations should clarify
whether nucleolar localization of topoisomerase II
could represent a further criterion to characterize cell
death, especially when considering recently identified
phenomena such as aponecrosis (Formigli et al., 2000)
and anoikis (Grossmann, 2002).
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